ESRRA and breast cancer: We found that, in all breast cancer cell lines examined, cholesterol and mevalonate treatment induced a significant increase in ERRα expression levels, as well as in the levels of the related protein PGC-1α—the coactivator needed for the activation of the ERRα pathway—by promoting mitochondrial biogenesis [44] (Figure 1).